| Name | Title | Contact Details |
|---|
Founded in 2014, Glyscend is dedicated to the development of a truly revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway.
LC Sciences is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Fette America is a Rockaway, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Exothera is a CDMO delivering customized process development and GMP production services for viral vectors in Belgium